Published in Int J Nanomedicine on December 13, 2012
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2007) 22.81
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Human induced pluripotent stem cells free of vector and transgene sequences. Science (2009) 17.16
Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol (2005) 13.90
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med (2003) 13.84
Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med (2006) 11.66
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell (2008) 10.34
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med (2008) 10.15
Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature (2004) 8.87
Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res (2001) 8.62
Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med (2003) 8.46
Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature (2004) 8.36
Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation (2002) 7.97
Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med (2006) 7.28
Hydrogels for tissue engineering. Chem Rev (2001) 7.25
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood (2004) 7.21
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 7.14
Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res (2009) 7.09
Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol (2007) 6.63
Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest (2001) 6.59
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation (2002) 6.50
Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res (2004) 6.49
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature (2003) 6.35
Decellularization of tissues and organs. Biomaterials (2006) 5.87
Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol (2004) 5.82
Stem-cell therapy for cardiac disease. Nature (2008) 5.75
Exploring and engineering the cell surface interface. Science (2005) 5.54
Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation (2003) 5.34
Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest (1999) 5.30
Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation (2004) 5.28
Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med (2006) 4.74
Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol (2005) 4.67
A tough biodegradable elastomer. Nat Biotechnol (2002) 4.35
Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB J (2007) 4.32
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog. Am J Physiol (1995) 4.08
Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation (2005) 4.03
Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest (1996) 3.87
Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve (1995) 3.84
Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol (2006) 3.78
Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation (2004) 3.71
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61
Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol (2004) 3.44
Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol (2006) 3.37
Heart failure. Lancet (2005) 3.33
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Growth of engineered human myocardium with mechanical loading and vascular coculture. Circ Res (2011) 3.25
Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science (1994) 3.24
Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation (1994) 3.24
Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ Res (2003) 3.22
The extracellular matrix as a biologic scaffold material. Biomaterials (2007) 3.18
Autologous transplantation of bone marrow cells improves damaged heart function. Circulation (1999) 3.17
Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperature-responsive cell culture surfaces. Circ Res (2002) 3.10
Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol (2003) 3.09
Cardiomyocyte cell cycle regulation. Circ Res (2002) 2.99
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation (2003) 2.97
Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs. Lancet (2004) 2.96
Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation (2009) 2.93
Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation (2005) 2.89
Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Heart Transplant Report-2009. J Heart Lung Transplant (2009) 2.85
Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers. J Clin Invest (2005) 2.80
Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A (2006) 2.75
Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood (2004) 2.72
Myoblast transplantation for heart failure. Lancet (2001) 2.71
Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol (2004) 2.69
Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts. Circulation (1999) 2.68
A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). J Biomed Mater Res (1993) 2.67
Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem (2009) 2.66
Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev (2008) 2.61
Formation of human myocardium in the rat heart from human embryonic stem cells. Am J Pathol (2005) 2.60
Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol (2009) 2.58
Stem cell differentiation requires a paracrine pathway in the heart. FASEB J (2002) 2.55
Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation (2003) 2.52
Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res (2003) 2.50
Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol (2006) 2.48
Organization of fibroblasts in the heart. Dev Dyn (2004) 2.47
Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng (2004) 2.42
Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials (2009) 2.41
Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study. Lancet (2005) 2.36
Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg (2005) 2.35
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30
Bioengineered cardiac grafts: A new approach to repair the infarcted myocardium? Circulation (2000) 2.25
Cell-based cardiac repair: reflections at the 10-year point. Circulation (2005) 2.25
Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials (2000) 2.24
A brief definition of regenerative medicine. Regen Med (2008) 2.22
Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A (2003) 2.21
Skeletal myoblast transplantation for repair of myocardial necrosis. J Clin Invest (1996) 2.20
Restraining infarct expansion preserves left ventricular geometry and function after acute anteroapical infarction. Circulation (1999) 2.19
Controlled growth factor release from synthetic extracellular matrices. Nature (2001) 2.15
Physiological coupling of donor and host cardiomyocytes after cellular transplantation. Circ Res (2003) 2.14
Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation (2005) 2.12
Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation (2004) 2.11
Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB J (2007) 2.10
Potential of nanofiber matrix as tissue-engineering scaffolds. Tissue Eng (2005) 2.19
Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy (2009) 1.98
Electrospinning of gelatin fibers and gelatin/PCL composite fibrous scaffolds. J Biomed Mater Res B Appl Biomater (2005) 1.79
Electrospun biomimetic nanocomposite nanofibers of hydroxyapatite/chitosan for bone tissue engineering. Biomaterials (2008) 1.66
Electrospun poly(epsilon-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering. Biomaterials (2008) 1.64
Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. Tissue Eng (2004) 1.58
Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51
Recent development of polymer nanofibers for biomedical and biotechnological applications. J Mater Sci Mater Med (2005) 1.41
Surface-aminated electrospun nanofibers enhance adhesion and expansion of human umbilical cord blood hematopoietic stem/progenitor cells. Biomaterials (2006) 1.41
Design strategies of tissue engineering scaffolds with controlled fiber orientation. Tissue Eng (2007) 1.40
Nano-featured scaffolds for tissue engineering: a review of spinning methodologies. Tissue Eng (2006) 1.32
Mesenchymal stem cell differentiation to neuronal cells on electrospun nanofibrous substrates for nerve tissue engineering. Biomaterials (2009) 1.29
Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials (2005) 1.26
Surface engineering of electrospun polyethylene terephthalate (PET) nanofibers towards development of a new material for blood vessel engineering. Biomaterials (2005) 1.18
Biomimetic electrospun nanofibers for tissue regeneration. Biomed Mater (2006) 1.18
Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. Tissue Eng (2005) 1.15
Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface (2011) 1.13
Advances in drug delivery via electrospun and electrosprayed nanomaterials. Int J Nanomedicine (2013) 1.12
Tissue engineered plant extracts as nanofibrous wound dressing. Biomaterials (2012) 1.10
An aligned nanofibrous collagen scaffold by electrospinning and its effects on in vitro fibroblast culture. J Biomed Mater Res A (2006) 1.08
Biomaterials and scaffolds for ligament tissue engineering. J Biomed Mater Res A (2006) 1.07
Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold. Biomaterials (2005) 1.07
In vitro study of human vascular endothelial cell function on materials with various surface roughness. J Biomed Mater Res A (2004) 1.06
Electrospun biocomposite nanofibrous scaffolds for neural tissue engineering. Tissue Eng Part A (2008) 1.05
Guided orientation of cardiomyocytes on electrospun aligned nanofibers for cardiac tissue engineering. J Biomed Mater Res B Appl Biomater (2011) 1.05
Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts. J Biomed Mater Res A (2009) 1.05
Advances in polymeric systems for tissue engineering and biomedical applications. Macromol Biosci (2012) 1.02
Enhanced biomineralization in osteoblasts on a novel electrospun biocomposite nanofibrous substrate of hydroxyapatite/collagen/chitosan. Tissue Eng Part A (2010) 1.02
Stem cell differentiation to epidermal lineages on electrospun nanofibrous substrates for skin tissue engineering. Acta Biomater (2011) 1.02
Precipitation of nanohydroxyapatite on PLLA/PBLG/Collagen nanofibrous structures for the differentiation of adipose derived stem cells to osteogenic lineage. Biomaterials (2011) 1.02
Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance. Acta Biomater (2005) 1.01
Applications of conducting polymers and their issues in biomedical engineering. J R Soc Interface (2010) 1.00
Novel hollow mesoporous 1D TiO2 nanofibers as photovoltaic and photocatalytic materials. Nanoscale (2012) 1.00
Rice grain-shaped TiO2 mesostructures by electrospinning for dye-sensitized solar cells. Chem Commun (Camb) (2010) 0.99
Formation of collagen-glycosaminoglycan blended nanofibrous scaffolds and their biological properties. Biomacromolecules (2005) 0.99
Nanofibrous structured biomimetic strategies for skin tissue regeneration. Wound Repair Regen (2012) 0.99
An efficient organic-dye-sensitized solar cell with in situ polymerized poly(3,4-ethylenedioxythiophene) as a hole-transporting material. Adv Mater (2010) 0.99
Degradation behaviors of electrospun resorbable polyester nanofibers. Tissue Eng Part B Rev (2009) 0.99
Nanobioengineered electrospun composite nanofibers and osteoblasts for bone regeneration. Artif Organs (2008) 0.98
Human umbilical cord Wharton's jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment. Stem Cell Rev (2012) 0.96
Application of conductive polymers, scaffolds and electrical stimulation for nerve tissue engineering. J Tissue Eng Regen Med (2011) 0.96
Electrosprayed nanoparticles and electrospun nanofibers based on natural materials: applications in tissue regeneration, drug delivery and pharmaceuticals. Chem Soc Rev (2015) 0.96
In vitro culture of human dermal fibroblasts on electrospun polycaprolactone collagen nanofibrous membrane. Artif Organs (2006) 0.95
Functional nanofiber scaffolds with different spacers modulate adhesion and expansion of cryopreserved umbilical cord blood hematopoietic stem/progenitor cells. Exp Hematol (2007) 0.95
Exceptional performance of TiNb₂O₇ anode in all one-dimensional architecture by electrospinning. ACS Appl Mater Interfaces (2014) 0.93
In vivo integration of poly(ε-caprolactone)/gelatin nanofibrous nerve guide seeded with teeth derived stem cells for peripheral nerve regeneration. J Biomed Mater Res A (2014) 0.93
Electrospun bio-composite P(LLA-CL)/collagen I/collagen III scaffolds for nerve tissue engineering. J Biomed Mater Res B Appl Biomater (2012) 0.93
Electrospun scaffold tailored for tissue-specific extracellular matrix. Biotechnol J (2006) 0.93
Activated carbons derived from coconut shells as high energy density cathode material for Li-ion capacitors. Sci Rep (2013) 0.93
Electrical stimulation of nerve cells using conductive nanofibrous scaffolds for nerve tissue engineering. Tissue Eng Part A (2009) 0.93
Structure and properties of electrospun PLLA single nanofibres. Nanotechnology (2005) 0.92
Exceptional performance of a high voltage spinel LiNi0.5Mn1.5O4 cathode in all one dimensional architectures with an anatase TiO2 anode by electrospinning. Nanoscale (2014) 0.92
Poly(Glycerol sebacate)/gelatin core/shell fibrous structure for regeneration of myocardial infarction. Tissue Eng Part A (2011) 0.91
Controlled release of bone morphogenetic protein 2 and dexamethasone loaded in core-shell PLLACL-collagen fibers for use in bone tissue engineering. Acta Biomater (2011) 0.91
Effects of nanotopography on stem cell phenotypes. World J Stem Cells (2009) 0.91
Anatase mesoporous TiO2 nanofibers with high surface area for solid-state dye-sensitized solar cells. Small (2010) 0.90
Effects of nanofiber/stem cell composite on wound healing in acute full-thickness skin wounds. Tissue Eng Part A (2011) 0.90
Manufacture of PLGA multiple-channel conduits with precise hierarchical pore architectures and in vitro/vivo evaluation for spinal cord injury. Tissue Eng Part C Methods (2009) 0.90
Electrospun conducting polymer nanofibers and electrical stimulation of nerve stem cells. J Biosci Bioeng (2011) 0.89
Study on the feasibility of bacteriorhodopsin as bio-photosensitizer in excitonic solar cell: a first report. J Nanosci Nanotechnol (2009) 0.89
A simple recipe for an efficient TiO2 nanofiber-based dye-sensitized solar cell. J Colloid Interface Sci (2010) 0.89
Fabrication of nanofibers with antimicrobial functionality used as filters: protection against bacterial contaminants. Biotechnol Bioeng (2007) 0.89
Processing nanoengineered scaffolds through electrospinning and mineralization suitable for biomimetic bone tissue engineering. J Mech Behav Biomed Mater (2008) 0.89
Biomimetic nanostructured materials: potential regulators for osteogenesis? Ann Acad Med Singapore (2011) 0.88
Facile fabrication of TiO2-graphene composite with enhanced photovoltaic and photocatalytic properties by electrospinning. ACS Appl Mater Interfaces (2012) 0.88
Electrospun nanofiber scaffolds for rapid and rich capture of bone marrow-derived hematopoietic stem cells. Biomaterials (2008) 0.88
Mechanical properties and in vitro behavior of nanofiber-hydrogel composites for tissue engineering applications. Nanotechnology (2012) 0.87
Encapsulation of proteins in poly(L-lactide-co-caprolactone) fibers by emulsion electrospinning. Colloids Surf B Biointerfaces (2009) 0.86
Electrospun composite nanofibers for tissue regeneration. J Nanosci Nanotechnol (2011) 0.86
Cobalt sulfide nanosheet/graphene/carbon nanotube nanocomposites as flexible electrodes for hydrogen evolution. Angew Chem Int Ed Engl (2014) 0.86
A novel process for the fabrication of nanocomposites membranes. J Nanosci Nanotechnol (2009) 0.86
Electrospun synthetic and natural nanofibers for regenerative medicine and stem cells. Biotechnol J (2012) 0.86
Elastomeric electrospun scaffolds of poly(L-lactide-co-trimethylene carbonate) for myocardial tissue engineering. J Mater Sci Mater Med (2011) 0.85
Ammonium Trifluoroacetate-Mediated Synthesis of 3,4-dihydropyrimidin-2(1H)-ones. ISRN Org Chem (2011) 0.85
Expression of cardiac proteins in neonatal cardiomyocytes on PGS/fibrinogen core/shell substrate for Cardiac tissue engineering. Int J Cardiol (2012) 0.85
A novel strategy to construct high performance lithium-ion cells using one dimensional electrospun nanofibers, electrodes and separators. Nanoscale (2013) 0.85